Large-insert genome analysis technology detects structural variation in Pseudomonas aeruginosa clinical strains from cystic fibrosis patients  by Hayden, Hillary S. et al.
Genomics 91 (2008) 530–537
Contents lists available at ScienceDirect
Genomics
j ourna l homepage: www.e lsev ie r.com/ locate /ygenoMethod
Large-insert genome analysis technology detects structural variation in Pseudomonas
aeruginosa clinical strains from cystic ﬁbrosis patients☆
Hillary S. Hayden a,⁎, Will Gillett a, Channakhone Saenphimmachak a, Regina Lim a, Yang Zhou a,
Michael A. Jacobs a, Jean Chang a, Laurence Rohmer b, David A. D'Argenio c, Anthony Palmieri a,1, Ruth Levy a,2,
Eric Haugen a, Gane K.S. Wong a,3, Mitch J. Brittnacher b, Jane L. Burns d, Samuel I. Miller b,c,e,
Maynard V. Olson a,b,e, Rajinder Kaul a,e
a Genome Center, University of Washington, Seattle, WA 98195, USA
b Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA
c Department of Microbiology, University of Washington, Seattle, WA 98195, USA
d Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
e Department of Medicine, University of Washington, Seattle, WA 98195, USAa r t i c l e i n f o☆ Sequence data from this article have been deposited
Data Libraries under Accession No. EU595733–EU59575
⁎ Corresponding author. Fax: +1 206 616 5242.
E-mail address: hhayden@u.washington.edu (H.S. Ha
1 Current address: Rosetta Inpharmatics Llc., 401 Ter
98109, USA.
2 Current address: Department of Immunology, Univ
WA 98195, USA.
3 Current address: Department of Biological Sciences
University of Alberta, Edmonton, AB, Canada.
0888-7543/$ – see front matter © 2008 Elsevier Inc. Al
doi:10.1016/j.ygeno.2008.02.005a b s t r a c tArticle history:
Received 13 November 2007
Accepted 28 February 2008
Available online 29 April 2008Large-insert genomeanalysis (LIGAN) is a broadlyapplicable, high-throughput technologydesigned to characterize
genome-scale structural variation. Fosmid paired-end sequences and DNA ﬁngerprints from a query genome are
compared toa reference sequenceusing theGenomicVariationAnalysis (GenVal) suiteof software tools topinpoint
locations of insertions, deletions, and rearrangements. Fosmids spanning regions that contain new structural
variants can then be sequenced. Clonal pairs of Pseudomonas aeruginosa isolates from four cystic ﬁbrosis patients
were used tovalidate the LIGAN technology. Approximately 1.5Mbof inserted sequenceswere identiﬁed, including
743 kb containing 615 ORFs that are absent from published P. aeruginosa genomes. Six rearrangement breakpoints
and 220 kb of deleted sequences were also identiﬁed. Our study expands the “genome universe” of P. aeruginosa
and validates a technology that complements emerging, short-read sequencing methods that are better suited to
characterizing single-nucleotide polymorphisms than structural variation.
© 2008 Elsevier Inc. All rights reserved.Keywords:
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Software toolsGenome structural variation, including large (N1 kb) insertions,
deletions, inversions, and translocations, contributes to genetic diver-
sity and disease susceptibility [1–3]. Structural variants have been
identiﬁed using several approaches [1,2]; however, except for direct
sequencing methods, these techniques have at least one of the fol-
lowing limitations: (1) they do not provide a genomic context for
variable regions and (2) they do not readily identify regions that
are not represented in the sequenced reference genome(s). The large-
insert genome analysis (LIGAN) technology reported here has the di-
stinct advantage of locating novel genomic sequences and rearrange-
ments in any genome of interest compared to sequenced reference
genomes. The conceptual framework for the technology is illustrated
in Fig. 1. It is based on a fosmid cloning strategy that limits insertswith the DDBJ/EMBL/GenBank
5.
yden).
ry Avenue North, Seattle, WA
ersity of Washington, Seattle,
and Department of Medicine,
l rights reserved.from approximately 32 to 48 kb in length; however, the technology
can utilize any double-stranded, clone-based data source.
Pseudomonas aeruginosa is a gram-negative bacterium that accounts
for 10 to 20% of nosocomial infections, themost serious ofwhich include
endocarditis, meningitis, pneumonia, and septicemia; and it is particu-
larly infectious in patients with burn wounds, acute leukemia, organ
transplants, and intravenous-drug addiction [4]. This ubiquitous envi-
ronmental bacterium also causes chronic pulmonary infections in
patients with cystic ﬁbrosis (CF). The ability of P. aeruginosa to thrive
in varied environmental habitats and its resistance to antibiotics and
disinfectants have led to its emergence as a major opportunistic patho-
gen. The versatility and vitality ofP. aeruginosa is due inpart to a genome
that contains an extensive collection of regulatory genes and multiple
resistance mechanisms [5]. Characterization of P. aeruginosa genome
diversity has contributed to the understanding ofmechanisms of patho-
genesis and factors that inﬂuence therapeutic outcomes [6,7]. Previous
studies of clinical and environmental strains suggest that the Pseudo-
monas genome consists of a conserved backbone with islands of chro-
mosomal genes that are variably present across strains [8]; thus,
P. aeruginosa has a population-based “supragenome” that is multiple
times the size of an individual strain's genome [9].
Fosmid libraries were generated for clonal pairs of P. aeruginosa
isolates from four cystic ﬁbrosis patients (Table 1). Fosmid end
Fig. 1. Schematic of LIGAN technology. One reference genome (Ref) and three query genomes (Q1, Q2, and Q3) are shown. Fosmid libraries are constructed from each query genome,
and paired-end sequences and DNA ﬁngerprints from multiple, complete digests (MCD) are generated from randomly picked clones providing 6–8× physical coverage of the query
genome. Clones are tiled against the reference sequence; fosmid paired-end sequences (green and orange arrows) anchor clone inserts and MCD ﬁngerprints are compared to virtual
reference-sequence-derived fragments. Deletions in the query genome are indicated when the apparent length of the anchored clone, based on paired-end sequences, is greater than
the physical clone insert length, based on MCD ﬁngerprints. Insertions in the query genome are indicated when the length of the anchored clone is less than the physical clone insert
length. Clones spanning inversion breakpoints have paired-end sequences that do not point toward each other and are thus inconsistent with a normal fosmid tiling, with or without
any of the insert size discrepancies described for deletions and insertions.
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clones from each library were analyzed using Genomic Variation
Analysis (GenVal) software to identify structural variants relative to the
P. aeruginosa PAO1 reference genome [5]. Deletions relative to PAO1
were reported earlier in ﬁve of the strains, PACS171b, PACS88, PACS416,
PACS5296, and PACS181, in the microarray study by Ernst et al. [10]. In
the present study, we conﬁrmed all of the deletions detected by
microarray analysis and, in addition, identiﬁed novel insertions and
genome rearrangements not detected by this earlier study [10]. Thus,
we used clinical strains of P. aeruginosa as a proof-of-principal model
system to establish LIGAN technology, and in the process, we un-
covered a greater diversity of structural variants in P. aeruginosa
clinical strain genomes than has been previously described.
Results
Principal of method
GenVal software (http://depts.washington.edu/uwgcmed/software.
html) uses fosmid paired-end sequences and restriction-enzyme DNA
ﬁngerprints from multiple, complete digests (MCD) [11] to determineall positions in the reference sequence where each of the clones
might reside; the accumulation of all such positions constitutes a tiling
(Fig. 2a). The tiling of fosmids from a query genome against a reference
sequence is used as the basis for structural variation analysis. GenVal
requires: (1) a reference genome sequence, (2) a query-strain-speciﬁc
ﬁle containing an aggregation of fosmid paired-end sequences and
MCD-ﬁngerprint data for the query genome, and (3) the fosmid vector
sequence. The reference sequence is used to anchor the fosmid paired-
end sequences and to create virtual sequence-derived fragments (SDFs),
which are compared to MCD gel fragments (GFs) of the query fosmids
(Fig. 2b). Theprocessproceeds in the followingmanner. First, paired-end
sequences are aligned to the reference sequence using the Smith–
Waterman algorithm [12] to establish clone boundaries along the re-
ference genome. If both end sequences for a clone align in the correct
orientation and within the length bounds of a fosmid, a full position is
formed; otherwise, one or more half positions may be formed. Half
positions occur for a number of reasons, including duplicated or repeat
sequences in the reference genome, large indels, rearrangements,
or absence of end-sequence data. Second, the software compares the
MCD-derived GFs to corresponding virtual SDFs within the bounds of
the anchors orwithin the estimated extent of a half position asdescribed
Table 1
Pseudomonas aeruginosa clinical strains (PACS) from CF patients and reference genomes
included in this study
Strain CF patient Patient
age
(months)
Sourcea Time
between
isolates
(years)
Alternate strain name in
previous studies
PACS171b 4 9 OP CF171b [10]; 3-0.8 [6]
PACS88 4 88 OP 6.5 CF4-88M [10]; 3-7.3 [6]
PACS458 102 27 OP G102A/27 mo. [29]; 5-2.3 [6]
PACS10223 102 115 OP
(muc)
7 5-9.6A [6]
PACS416b 9 6 OP G9A/6 mo. [29]; CF416 [10],
Patient One 6-mo. isolate [6]
PACS5296b 9 96 Sputum 7.5 CF5296 [10]; Patient One
96-mo. isolate [6]
PACS181 206 12 BAL G206A/12 mo. [29]; CF181
[10]; 206-12 [37]; 6-1.0 [6]
PACS2069 206 115 OP 8.5 6-9.6A [6]
PA01 Laboratory
strain
na Human
wound
na None
PACS2b 9 6/96 OP/
sputum
7.5 None
PA14 Laboratory
strain
na Human
wound
na None
a Clinical strains were isolated from sputum, the upper airway by a swab of the
oropharynx (OP), or the lower airway by bronchoalveolar lavage (BAL). PACS10223
had a mucoid phenotype (muc) as indicated.
b PACS416 and PACS5296 were sequenced and assembled as a combined ﬁnished
genome called PACS2 (GenBank accession NZ_AAQW00000000).
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formeasurementerrors (supplementarymaterial). User-deﬁned thresh-
olds in the software determine both the creation of end sequence
anchors and the pairing of GFs and SDFs.
The GFs resulting from restriction digests of fosmids include:
(1) vector fragments, (2) junction fragments composed of part insert
and part vector DNA, and (3) insert fragments derived from the
fosmid-insert DNA. During the matching process, all GFs resulting
from digestion are accounted for, including vector fragments, junction
fragments, and insert fragments. If, for all restriction digests, the one-
to-one correspondence includes all GFs and all SDFs, the position is
considered perfect; otherwise, it contains defects of one or more
forms. A defect is present if there is: (1) an unpaired SDF, known as
map residue; (2) an unpaired GF, known as ﬁngerprint residue; (3) a
vector fragment that cannot be identiﬁed, known as vector-fragment
residue; or (4) a junction fragment that cannot be identiﬁed, known as
junction-fragment residue. Such defects are properties by which
positions are categorized and ﬁltered in GenVal. For half positions, the
extent of the unanchored clone insert end is determined by a binary
search approach; that is, the software searches for the end, along the
virtual restriction map of the reference sequence, that minimizes the
number of defects.Fig. 2. Graphical user interfaces (GUIs) in GenVal. (a) The Tiling GUI illustrates a region of a t
the reference sequence are displayed, 1×, 2×, and 3× fosmid coverage is indicated by black lin
The plot of the average insert length difference is displayed in Panel 2. In Panel 3, each clone p
end sequences aligned to the reference sequence. The colors within each rectangle illustrat
sequences align to the reference sequence, (2) half-combined position in which only one en
length, (4) plot of the average insert length difference indicating the insertion identiﬁed in N
right-anchored-half positions ﬂanking the left and right edges of a large insertion, respectiv
including position type, clone name, reference sequence coordinates of clone anchors, qualit
alignment (Smith–Waterman score and length), number of each type of defect, total contou
length across digests. (b) The Sequence to Fingerprint GUI, produced by a right mouse click
position match the SDFs from the virtual restriction map of the reference sequence. Coord
restriction-enzyme digest the SDFs spanned by and adjacent to the clone position and the ma
sequence that are part of the XhoI sitemap; (2) an example SDF delimited by two XhoI restric
SDF directly above it; (4) an unpaired NcoI SDF; and (5) an unpaired NcoI GF. The solid cyan
the reference sequence as deﬁned by the anchoring of clone end sequences. The colored recta
corresponding SDF. A summary of unpaired SDFs and GFs is provided at the far left in panels 2
and other features can be obtained in Panel 5 by clicking on any of the features discussed aGenVal can produce three different types of clone positions: com-
bined, end sequence, and ﬁngerprint. A combined position is created
when there is signiﬁcant matching of the fosmid GFs to the virtual
SDFs within the bounds of a full position that is deﬁned by the paired-
end sequences or within the estimated extent of a half position. Com-
bined positions provide the most precise information for structural
variation analysis, because the end sequence anchoring delimits a
given region of interest and the ﬁne-grained ﬁngerprint matching
pinpoints the location and size of the variation in that region. In
contrast, an end sequence position is created when either (1) ﬁnger-
print data are unavailable for a clone or (2) signiﬁcant mismatching
occurs between the GFs and the SDFs within the bounds of a full
position or within the estimated extent of a half position. A ﬁngerprint
position is created when (1) no combined position can be created,
because either the end sequences are unavailable or they do notmatch
the reference sequence, and (2) there is signiﬁcant matching of GFs
and SDFs along the reference genome. A two-pronged binary search is
applied simultaneously at both ends of the fosmid to delimit ﬁnger-
print positions.
GenVal automatically compiles all potential locations of structural
variation into a “regions of interest” table (not shown) for review and
further analysis. The software identiﬁes structural variants less than
an average fosmid length using the average insert length difference
(Fig. 2a), which is the difference between estimates of the clone insert
lengths from the end-sequence anchors and the average-insert-size
estimates from MCD ﬁngerprints. At insertion sites where the query
strain contains more DNA than the reference, the clone lengths based
on the end-sequence anchors are shorter than those based on the
MCD ﬁngerprints (Fig. 1). In contrast, at deletion sites where the query
strain contains less DNA than the reference, the clone lengths based on
the end-sequence anchors are longer than those based on the MCD
ﬁngerprints (Fig. 1). GenVal identiﬁes structural variants greater than
an average fosmid length using the orientation of clusters of clones
that tile with half positions (Fig. 2a). For insertions larger than typical
fosmid length, the clones spanning the insertion boundary have
only one end sequence that aligns with the reference sequence, the
other end being speciﬁc to the query strain. A unique cluster of clones
with half positions, deﬁned as “edge clones,” occurs on each side of
large insertions (Fig. 2a). Deletions larger than a typical fosmid length
are bracketed by two nonoverlapping clusters of half positions, each
cluster containing the same set of clones (not shown). Similar to large
deletions, breakpoints delimiting inversions and other rearrange-
ments larger than typical fosmid length are ﬂanked by nonoverlap-
ping clusters of half positions; however, at breakpoints each cluster
contains a different set of clones (Fig. 1). Based on the breakpoints,
GenVal decomposes the reference sequence into segments and
reassembles these segments in the order and orientation that they
occur in a query strain to provide an overview of the structure of the
query strain's genome (not shown).
The software's de novo contig building utility, which is based on the
classical algorithmic contig-building approach of sorting probabilitiesiling of query genome fosmids against the reference sequence. In Panel 1, coordinates of
es. In this example, 1× coverage is contiguous, while the 2× and 3× coverages have gaps.
osition is represented by a rectangle. Blue dots at the edges of rectangles indicate fosmid
e various features of the clone position. (1) Full-combined position in which both end
d sequence aligns, (3) full-combined position spanning an insertion less than a fosmid
o. 3 above, and (5) ﬁve clones with left-anchored-half positions and three clones with
ely. Detailed information about each clone position can be obtained readily in Panel 4,
y and length of each end sequence read (as Q20 score and length) and the quality of its
r (and insert) lengths of the clone from each restriction digest, and the average insert
on a clone position, illustrates how the GFs from MCD ﬁngerprints of a clone at a given
inates of the reference sequence are displayed in Panel 1. Panels 2–4 display for each
tching of the GFs to the SDFs. (1) Two example restriction site locations in the reference
tion sites; (3) one GF resulting fromXhoI digestion of the clone, this GF is pairedwith the
line above the SDFs in each enzyme panel illustrates the extent of the clone insert along
ngles above the cyan line provide information about the match quality of each GF to the
–4. An “OK” indicates the absence of any residues. Detailed information about SDFs, GFs,
bove.
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clones that did not tile against the reference sequence and clones that
span large insertion boundaries (supplementary material). GenVal
uses a surrogate metric for the probability of overlap, the Composite
Mutual Overlap Statistic (CMOS). The CMOS is computed over all
restriction enzyme domains and involves the ratio of the number of
restriction fragments that are apparently in common between two
clones to the number of fragments that are present in each clone. A
CMOS threshold that implies roughly a 50% clone overlap is most
effective for such contig building. Contig building is valuable for
placing large insertions in the context of the query genome and for
identifying a minimum set of clones to sequence.
An approach related to LIGAN, called the pair-end sequencing
method, has been used in Francisella tularensis [15]; however, it relied
on long-range PCR of λ phage clone inserts to measure the physical
distance between paired-end reads and did not provide ﬁne-grained
details about structural variants or an opportunity for de novo contig
building, which are available with LIGAN technology.
Structural variation analysis of P. aeruginosa clinical strains
For the present study, inputs to GenVal software were: (1) the
P. aeruginosa PAO1 reference genome sequence [5] and (2) for each
P. aeruginosa clinical strain (PACS) a ﬁle containing the pCC1Fos vector
sequence and an aggregation of fosmid paired-end sequences andMCD-
ﬁngerprint data. Regions exhibiting structural variation, and represen-
tative clones spanning them, were compiled for each query genome
in the software's region of interest table. Regions of interest were
validated bymanual review of the tiling of each query genome. A region
was chosen for more detailed analysis when: (1) it was spanned by a
minimumof three clones—the third clone provided a tie-breaker in case
the other twoproducedmixed signals—and (2) the average insert length
difference was 3 kb or greater, which is 2.5 standard deviations in the
average insert length difference for the “self” tiling of PAO1 fosmids
against the PAO1 genome. These thresholds resulted in no false positives
and one false negative in our control experiments (discussed below).
A set of clones spanning each unique rearrangement breakpoint was
sequenced from a single isolate. Insertions in each isolate were further
investigated in the following manner. First, representative clones span-
ning insertions less than a fosmid length, edge clones ﬂanking and
extending into insertions greater than a fosmid length, and the subset of
clones that did not tile against PAO1were tiled against the PA14 genome
[16] and the combined assembly of the sequenced PACS416 and
PACS5296 genomes (Table 1), called PACS2 (GenBank Accession No.
NZ_AAQW00000000, supplementary material). If a fosmid matched a
region of the PA14 or PACS2 genome, the clone was considered to
contain previously characterized DNA and was annotated based on the
matching reference genome. Clones spanning insertions less than a
fosmid length without a match were sequenced to identify the strain-
speciﬁc DNA.
All clones that did not tile against the three reference genomes and
edge clones ﬂanking novel insertions were further analyzed by deTable 2
Insertions, deletions, and rearrangement breakpoints in PACS isolated from Patients 4, 102,
CF
patient
Strain No. total
insertions
No. insertions shared with
other strainsa
No. strain-speciﬁc
insertions
206 PACS181 7 3 4
PACS2069 7 3 4
102 PACS458 12 3 9
PACS10223 12 3 9
4 PACS171b 14 3 11
PACS88 14 2 12
Total 66 17 49
a The number of GenVal-predicted insertions containing DNA that is absent from the re
Accession No. NZ_AAQW00000000) and/or PA14 (GenBank Accession No. NC_008463).novo contig building. Clones from contigs composed of paired-edge
clones, with or without a minimal tiling path of internal clones, were
sequenced for further investigation.
Control experiments using isolates PACS416 and PACS5296 from CF
Patient 9
Four pairs of early–late PACS from CF patients were analyzed in the
current study (Table 1). Paired-end sequences and ﬁngerprints from
NcoI, SmaI, and XhoI restriction digests were attempted for 960 inde-
pendent fosmid clones per isolate. The PACS2 assembly provided an
experimental control for LIGAN studies of the PACS416 and PACS5296
genomes from Patient 9. Based on the 913 PACS416 and 915 PACS5296
clones that tiled against PAO1, GenVal predicted 15 insertions, 11
deletions, and 2 rearrangement breakpoints for PACS416 and pre-
dicted the same events for PACS5296 with two exceptions: (1) one
additional rearrangement breakpoint and (2) a 188-kb deletion span-
ning 139 genes in PAO1 (Supplementary Table 1). Of the 47 PACS416
clones that did not tile against PAO1,10 had incomplete or poor quality
data, and the remaining 37 tiled against PACS2 in regions that are
either entirely absent from or highly discrepant in structure in the
PAO1 genome [5]. Of the 45 PACS5296 clones that did not tile against
PAO1, 2 had incomplete or poor quality data and the remaining 43
clones tiled against PACS2 in unique or hypervariable regions relative
to PAO1.
A previous PAO1-based microarray study [10] and direct compar-
ison of the PACS2 and PAO1 sequences conﬁrmed all of the GenVal-
predicted regions of interest, except for a single structural variant
N3 kb in size in PACS416 at the pyoverdine locus (2.65 Mb in PAO1).
This was not initially included as a region of interest because the
fosmid coverage was below the three-clone minimum threshold. De-
spite low coverage, clones tiled at this site signaled a deletion.
In total, 6% of the PACS416 and PACS5296 genomes is not re-
presented in the PAO1 genome. One percent of the PAO1 genome is
missing from the PACS416 genome, and 3% is missing from the
PACS5296 genome. Thus, structural variants accounted for up to 9% of
the genomic variation in these Pseudomonas isolates compared to the
PAO1 reference sequence.
Structural variation in early–late paired clinical isolates from CF Patients
4, 102, and 206
A total of 66 insertions were identiﬁed in the paired isolates from
Patients 4,102, and 206 (Table 2).With only two exceptions in Patient 4
(discussed below), therewas concordance of insertions in the early and
late isolates in eachpatient. Seventeenof the 66 insertionswere shared
with the isolates from Patient 9 described above or P. aeruginosa strain
PA14 and were thus annotated accordingly without further analysis.
Nine of these 17 shared insertions contained previously characterized
genomic islands: (1) the clc element encoding genes for chlorocha-
techol-degrading enzymes [17]; (2) PAGI-1 (for P. aeruginosa genomic
island 1), which may confer protection against oxidative damage [18];and 206
No. insertion clones
sequenced
No. total
deletions
No. rearrangement
breakpoints
No. rearrangement
clones sequenced
5 6 5 3
0 7 6 0
11 8 2 0
3 8 2 0
15 8 5 0
1 8 6 1
35 45 19 4
ference PAO1 genome but present in sequenced P. aeruginosa strains PACS2 (GenBank
Table 3
Summary of annotation for strain-speciﬁc insertions
Early/late isolates
(CF patient)
Insertion PAO1 ORFs
affecteda
PAO1 genes in
affected ORFsb
No. of
inserted
ORFs
Functionality of inserted
DNA sequence
GenBank
accession
no.
PACS181/PACS2069 (206) 1 PA0041–42 Hemaglutinin 3 Hp EU595733
2 PA1150–52 pys2, imm2, hp 6 Toxin production/export EU595734
3 PA2603–04 tRNA-ser 44 PhiCTX cytotoxin-converting phage EU595735
4 PA3367–68 tRNA-arg 18 Transposase, replicase, helicase, hp EU595755
PACS458/PACS10223 (102) 1 PA1142–43 Transcription regulator, hp 14 Pyocin S3, recombinase, hp EU595736
2 PA1426–27 Hp 8 Biodegradation EU595737
3 PA1659–60 Hp 50 Bacteriophage B3 EU595738
4 PA2419–20 Hydrolase, porin 8 Hp EU595739
5 PA2583–86 tRNA-gly 63 Bacteriophage EU595740
6 PA2601–09 tRNA-ser 66 Bacteriophage EU595742
7 PA2683–84 Ser/thr dehydratase, hp 10 Amino acid transport/metabolism EU595741
8 PA3663–64 Hp 57 Bacteriophage F116 EU595743
9 PA5160–61 tRNA-thr 8 Transposase, hp EU595744
PACS171b/PACS88 (4) 1 PA0263–64 tRNA-arg 39 Bacteriophage EU595745
2 PA0527–28 rsmY 49 Type IV secretion, metal transport EU595746
3 PA0822–26 tmRNA 31 Defense proteins, hp EU595747
4 PA2218–21 opdE, transcription regulator 61 PAGI-1, PAGI-4 EU595748
5 PA2593–94 Hp, pvdN 19 Pyoluteorin biosynthetic gene cluster EU595749
6 PA2749 endA 30 Tellurite resistance operon EU595750
7 PA3620 mutS 58 Bacteriophage proteins EU595751
8 PA3768–69 Metallo-oxidoreductase, guaA 20 Transposase, hp EU595752
9c PA4598–99 mexD, mexC 13 PAGI-4 EU595754
10 PA4673–74 tRNA-Met 16 Bacteriophage pf1 EU595753
Total 23 691d
a Bold text indicates PAO1 ORFs that have no alignment to sequence from fosmid(s) spanning insertion.
b Hypothetical protein is abbreviated as “hp” in PAO1 genes and functionality columns. Information about PAO1 genes can be found at http://www.pseudomonas.com/index.jsp.
c Insertion found in late strain PACS88 only.
d Although 691 ORFs were identiﬁed in the strain-speciﬁc insertions, only 615 of these were unique.
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pKLC102 genomic island was present in the early isolate of Patient 4,
but was conspicuously absent from the late isolate. The remaining 8 of
these 17 shared insertions contained Rhs elements andDNA sequences
that aligned to PAO1 open reading frames (ORFs) from disparate
regions of the PAO1 genome. Rhs elements are complex sequences that
include a 3.7-kb GC-rich core ORF putatively encoding a cell surface
ligand-binding protein, a highly variable second ORF carrying a cyto-
plasmic membrane transport signal, and one or more insertion se-
quences [20]. Some Rhs elements, including one insertion in isolates
from Patient 206, also include an upstream “vgr” component (for Val–
Gly dipeptide repeat motif) that is a marker for genomic islands in
P. aeruginosa [10].
Forty-nine insertions from 25 regions, 24 of which were unique
relative to PAO1, were PACS-strain-speciﬁc (Table 2). Thirty-ﬁve fosmids
spanning 23 of these regions were sequenced to provide complete
coverage of the insertions. Two insertion regions common to both
strains from Patient 4 were not investigated (not shown), because
initially they were identiﬁed as being shared with the isolates from
Patient 9. Annotation of the sequenced insertions revealed ORFs en-
coding a range of functions, including toxin production, metabolism,
secretion, and biodegradation, in addition to bacteriophages and
uncharacterized ORFs. An annotation summary is reported in Table 3.
The paired early and late isolates from a given patient shared all strain-
speciﬁc insertions, with the exception of a second copy of 13 ORFs
from PAGI-4 [19] that was found only in the late strain from Patient 4.
This insertion in the late isolate, in conjunction with the deletion of
the pKLC102 genomic island (discussed above), suggests either that the
early and late isolates from Patient 4 are not clonal or that the late
strain lost DNA, and acquired a second copy of PAGI-4 ORFs, while
residing in the host. The latter seems more likely, given support for
clonality of PACS171b and PACS88 from multilocus sequence typing [6]
and the extent of shared structural variation among these two isolates
(Table 3). Two copies of similar DNA sequence also were found in
isolates from Patient 102, in which the same uncharacterized bac-
teriophage was inserted at PA2583.1 tRNA-Gly and PA2603.1 tRNA-Ser.Coincidentally, this tRNA-Ser gene was the sole example in our study
of unrelated strains sharing an insertion site. The φCTX cytotoxin-
converting phage [21] was inserted into this gene in both isolates from
Patient 206.
A total of 45 deletions from 12 regions were found in the paired
isolates from Patients 4, 102, and 206 (Supplementary Table 2). In
comparison to DNA microarrays, GenVal-predicted deletions were
relatively broad in scope due to the software's dependence on MCD-
ﬁngerprint data, and no further sequence analysis was conducted to
ﬁne-tune these regions. Despite this, all GenVal-predicted deletions in
PACS171b and PACS88 from Patient 4 and PACS181 from Patient 206
overlapped with those reported by the DNA microarray analysis of
Ernst et al. [10], with one exception (Supplementary Table 2);
however, a minimum of 12 ORFs, including putative enzymes and
hypothetical proteins, were absent in this region in 12 of the 20 strains
in the Ernst et al. study, suggesting that these PAO1 ORFs are com-
monly absent in other Pseudomonas strains. Additional deletions
identiﬁed by microarray but absent from GenVal predictions either
were smaller than our 3-kb threshold or overlapped with larger
insertions and were characterized as such by the software.
Six unique rearrangement breakpoints were found in the six isolates
(Supplementary Table 2). Twoof these breakpointswere also sharedwith
Patient 9 isolates and delimit an inversion that resulted from a homo-
logous recombination event between rrnA and rrnB previously identiﬁed
as unique to the reference sequence PAO1 isolate [5]. Three other break-
points were identiﬁed in all isolates from Patient 4 and Patient 206 and
were validated by sequencing three fosmids from PACS181. One ad-
ditional breakpoint, found in the late isolates from Patient 4 and Patient
206, was conﬁrmed by sequencing a fosmid from PACS88.
Discussion
We have demonstrated the ability of LIGAN technology to character-
ize structural variation in four pairs of early–late isolates of P. aeruginosa
from CF patients. In particular, we have used the technology to identify
genomic islands that are variably present across strains and have been
536 H.S. Hayden et al. / Genomics 91 (2008) 530–537shown to account for 10% or more of a given genome [8]. These islands
are often ﬂanked by repeat sequences and are frequently adjacent to
tRNA genes [1]. Indeed, seven of the strain-speciﬁc islands sequenced in
the present study were adjacent to tRNA genes (Table 3), as were three
of the islands shared with PACS2 and/or PA14. Genomic islands can be
created by integration into the host chromosome by the use of various
mobile genetic elements, including plasmids, bacteriophages, and
transposons. Such elements are abundant in our results (Table 3).
Known genomic islands identiﬁed in our study include the pyoluteorin
biosynthetic cluster, the tellurite-resistance operon, PAGI-1, PAGI-4, and
ﬁve integrated bacteriophages, φCTX, B3, F10, F116, and Pf1. Four
additional bacteriophage-containing regions include genes encoding
integrases, phage capsid and tail proteins, and various numbers of
hypothetical proteins with similarity to previously identiﬁed bacter-
iophages. These ﬁndings suggest that known Pseudomonad bacter-
iophages may be more widespread across strains than previously
recognized and that there are additional bacteriophages yet to be
described that commonly infect P. aeruginosa strains.
LIGAN technology overcomes the two major limitations of existing
methods for detecting structural variants by readily identifying
genomic regions that are not represented in the sequenced reference
strain(s) and providing a genomic context for variable regions. Fur-
thermore, results from LIGAN studies can be readily integrated with
other experimental approaches to provide a more comprehensive
strategy for investigating genetic variation. For example, novel DNA
sequences identiﬁed using LIGAN technology can expand “universal”
microarray chips, and information about the structure of a query
genome can help place short DNA sequence reads from new se-
quencing technologies [22], such as “sequencing by synthesis” or
“sequencing by hybridization,” into the context of the whole genome.
These ultra-high-throughput sequencing technologies produce
sequence data at a signiﬁcantly increased depth of coverage and at
reduced costs; however, these technologies produce short reads that
are about 30–40 (Solexa and ABI SoLID technologies) or 100–200 (454
technology) bases long. These sequence data have primarily been
used to tile and assemble query genomes against a known reference
genome [23]. The current study has revealed that Pseudomonas ge-
nomes can be 3–9% structurally variant from a reference genome.
Assembling against reference genomes will reveal most of the single-
nucleotide polymorphisms and other small genetic differences, but
will not be able to place reliably structurally variant regions in the
context of reference genomes. For example, observed deleted
sequences could be due to a lack of data acquisition from the affected
regions; and novel insertions, as well as inversions and transloca-
tions, would be more difﬁcult to detect and to place in the query
genome. Furthermore, as noted by Bentley [23] with regard to de
novo assembly of genomes with data generated by ultra-high-
throughput sequencing technologies, “multiple new strategies will
be developed for recovering speciﬁc fractions of sequence (e.g. those
generated by long PCR or hybrid selection) that might be missed in a
ﬁrst round of [ultra-high-throughput] sequencing.” LIGAN technology
offers the appropriate tools to be able to identify and characterize
such regions.
Structural variation in the human genome is receiving much
attention, because structural variants contribute signiﬁcantly to
human diversity and disease susceptibility [2,24]. As LIGAN
technology was being developed, it was used partially to reﬁne
structural variation analysis of the human genome [24–26] and to
deﬁne the contribution of structural variants to euchromatic gaps
[27] in the ﬁnished human genome assembly [28]. In all of these
studies, GenVal software was used to validate whether a fosmid
clone spanning a potentially variant locus was indeed structurally
variant by comparing the fosmid paired-end sequence and the
MCD ﬁngerprint data with the corresponding sequence region
derived from the reference human genome assembly [24–27].
LIGAN technology is thus universally applicable and highly scalableand allows genome-scale structural variation analysis of any
species for greater understanding of the extent of genome
diversity.
Materials and methods
Bacterial strains
P. aeruginosa strains used in this study are listed in Table 1. Clinical isolates from a
given patient are considered to be clonal based on multilocus sequence typing [6].
Initial isolation and culture of PACS are described in Burns et al. [29].
Fosmid libraries
Chromosomal DNA of each isolate was extracted from 25-ml overnight Luria broth
cultures using Genomic-Tip 100/G or DNeasy protocols (Qiagen, Valencia, CA, USA). The
amount of high-molecular-weight genomic DNA was assessed by pulsed-ﬁeld gel
electrophoresis in a DRIII CHEF gel apparatus (Bio-Rad, Hercules, CA, USA). Deep fosmid
libraries were constructed in the pCC1Fos vector (Epicentre, Madison, WI, USA) ac-
cording to the standard protocols described earlier [30]. Independent fosmid clones
were randomly picked and arrayed into 384-well plates, each well containing 90 µl of
freezingmedium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 6.3 g/L K2HPO4,1.8 g/L
KH2PO4, 0.5 g/L sodium citrate, 0.9 g/L (NH4)2SO4, 4.4% glycerol) supplemented with
12 µg/ml tetracycline. Plates were incubated for 18 h at 37 °C, then frozen, and stored at
−80 °C.
Fosmid paired-end and shotgun sequencing
Fosmid DNA was isolated in a 96-well format using the CosMCPrep kit (Agencourt
Biosciences Corp., Beverly, MA, USA) and sequenced with the BigDye Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) using the forward
(GTTTTCCCAGTCACGACGTT) and reverse (GCGGATAACAATTTCACACAGGAA) sequencing
primers. The target mate-pair end-sequence success rate was N85% with minimal
sequence quality of 100 Q20 (error probability of 1:100) bases per read.
Selected fosmid clones were subjected to shotgun sequencing, as described [31].
The shotgun sequence data were assembled and viewed using PHRED/PHRAP/CONSED
software tools [32–34]. The sequence quality and contiguity of the shotgun data were
improved, initially by carrying out three rounds of experiments designed by the
Autoﬁnish tool in Consed [35], followed by directed ﬁnishing experiments designed by
an expert ﬁnisher, as previously described [36].
Fosmid DNA ﬁngerprinting
Fosmid DNA was isolated using a standard alkaline-lysis protocol in a 96-well
format. Final DNA pellets were dissolved in 40 µl 1×TE buffer (pH 8.0) supplemented
with RNase A and RNase T1 to ﬁnal concentrations of 5 and 0.05 U/µl, respectively. Six-
microliter aliquots of fosmid DNAwere independently digested in 10-µl reactionswith 5
units each of NcoI, SmaI, and XhoI restriction enzymes and incubated for 2 h at 37 °C.
Five-microliter aliquots of digested DNA samples were loaded into 0.8% agarose gels (gel
dimension 19×19×0.5 cm). Each gel contained 53 lanes, including 48 lanes of digested
fosmid DNA samples in four equal sets interspersed between ﬁve marker lanes (1 kb
DNA Extension Ladder; Invitrogen, Carlsbad, CA, USA). Gel electrophoresis was carried
out in 2× GGB buffer [11] at 8 V/cm in a custom-made chamber holding four gels
with 4 °C circulating buffer for 17–18 h. Gels were stained for 1 h with SYBR Green I
(Invitrogen) diluted 1:20 in 2× GGB. The stained gels were scanned on a Typhoon 8600
variable mode imager (Amersham Biosciences, Piscataway, NJ, USA). The digital gel
images were analyzed with Quantitative Gel Analysis Program (QGAP) software
developed at UWGC (http://depts.washington.edu/uwgcmed/software.html) that pro-
vided estimates of the size and fragmentmultiplicity of each band. An important quality
control step involved comparing the size estimates from three separate restriction
digests for each fosmid. The average deviation of these size estimateswas approximately
5% for all clones in this study; however, the deviation ranged up to 30%, because of
spurious band calls or the presence of few, or no, sites for a particular enzyme. Gel lanes
with spurious band calls were manually edited, but this practice involved b2% of the
sample lanes.
Sequence annotation
Novel sequences were manually annotated as previously described [36] with the
Prokaryotic Genome Annotation Tool (http://depts.washington.edu/ventures/
UW_Technology/Express_Licenses/pgat.php). ORFs of greater than 30 amino acids
were predicted by GLIMMER and were subsequently checked manually. Candidate
ORFs were investigated for coding sequence by comparison to the COG (http://www.
ncbi.nlm.nih.gov/COG/), PFAM (http://www.sanger.ac.uk/Software/Pfam/), PROSITE
(http://us.expasy.org/prosite/), and Gene Ontology (http://www.geneontology.org/)
databases. Subcellular locations of putative proteins were predicted using PSORT-B
(http://www.psort.org/psortb/), TMHMM (http://www.cbs.dtu.dk/services/TMHMM/),
1and SignalP (http://www.cbs.dtu.dk/services/SignalP/). BLASTX was used to
compare clinical strain sequences to GenBank sequences (http://www.ncbi.nlm.
nih.gov/BLAST/).
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